Expert Exchange: SpaceX plummets back down to earth after explosive IPO debut
SpaceX has revisited its $135 listing price after an explosive IPO as investors reassess lofty valuations ahead of its first earnings report.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| CDY | CELLMID SECURES BLOOMINGDALES USA PARTNERSHIP FOR EVOLIS | PRICE SENSITIVE | 24/04/18 | |
| CDY | Appendix 4C - quarterly | PRICE SENSITIVE | 23/04/18 | |
| CDY | Cellmid Investor Presentation | 10/04/18 | ||
| CDY | CELLMID CONVENING 5TH MIDKINE SYMPOSIUM IN MUNICH | 09/04/18 | ||
| CDY | CELLMID SIGNS DISTRIBUTION AGREEMENT FOR FILLERINA | PRICE SENSITIVE | 04/04/18 | |
| CDY | Change of Director's Interest Notice-Halasz | 29/03/18 | ||
| CDY | Initial Director's Interest Notice | 26/03/18 | ||
| CDY | CELLMID APPOINTS DENNIS ECK NON-EXECUTIVE DIRECTOR | 26/03/18 | ||
| CDY | Change of Director's Interest Notice-Halasz | 14/03/18 | ||
| CDY | Appendix 4D and Half Year Accounts | PRICE SENSITIVE | 22/02/18 | |
| CDY | Nature Paper MK in Melanoma | PRICE SENSITIVE | 03/07/17 | |
| CDY CELLMID SECURES BLOOMINGDALES USA PARTNERSHIP FOR EVOLIS | |||
| 24/04/18 | PRICE SENSITIVE | ||
| CDY Appendix 4C - quarterly | |||
| 23/04/18 | PRICE SENSITIVE | ||
| CDY Cellmid Investor Presentation | |||
| 10/04/18 | |||
| CDY CELLMID CONVENING 5TH MIDKINE SYMPOSIUM IN MUNICH | |||
| 09/04/18 | |||
| CDY CELLMID SIGNS DISTRIBUTION AGREEMENT FOR FILLERINA | |||
| 04/04/18 | PRICE SENSITIVE | ||
| CDY Change of Director's Interest Notice-Halasz | |||
| 29/03/18 | |||
| CDY Initial Director's Interest Notice | |||
| 26/03/18 | |||
| CDY CELLMID APPOINTS DENNIS ECK NON-EXECUTIVE DIRECTOR | |||
| 26/03/18 | |||
| CDY Change of Director's Interest Notice-Halasz | |||
| 14/03/18 | |||
| CDY Appendix 4D and Half Year Accounts | |||
| 22/02/18 | PRICE SENSITIVE | ||
| CDY Nature Paper MK in Melanoma | |||
| 03/07/17 | PRICE SENSITIVE | ||
